FindTrial
Sign In

A study to Compare Quality of Life and side effects in patients undergoing Medical versus Surgical Castration in Metastatic Prostate cancer at Tata Memorial Hospital.

A Prospective, Observational study to Compare Quality of Life and side effects in patients undergoing Medical versus Surgical Castration in Metastatic Carcinoma of Prostate at Tata Memorial Hospital.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/03/024111
Enrollment
300
Registered
2020-03-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C61- Malignant neoplasm of prostate

Interventions

Control Intervention1: NIL: NIL

Sponsors

Tata Memorial Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients with metastatic carcinoma prostate planned to receive either GnRH agonist / antagonist or surgical orchiectomy. 2)ECOG Criteria of 0,1,2. 3) Patient willing to undergo treatment and follow up at our centre.

Exclusion criteria

Exclusion criteria: 1) Those not willing to comply with study procedures. 2) Patients with performance status of 3,4.

Design outcomes

Primary

MeasureTime frame
To compare the quality of life between the patients undergoing medical and surgical castration.Timepoint: 2 years—

Secondary

MeasureTime frame
1. To compare the side effects between the patients undergoing medical and surgical castration. 2. To compare the expenditure of the treatments in the patients undergoing medical and surgical castration. Timepoint: 2 years—

Countries

India

Contacts

Public ContactDr Amit Joshi

Tata Memorial centre

dramitjoshi74@gmail.com022-24176755

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026